Donor pretreatment with leflunomide has an adverse effect on rat cardiac allograft survival.

[1]  M. Waer,et al.  Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts. , 1996, Transplantation proceedings.

[2]  J. Buckels,et al.  THE IMMUNOMODULATORY EFFECT OF LEFLUNOMIDE IN RAT CARDIAC ALLOTRANSPLANTATION , 1995, Transplantation.

[3]  J. Wright,et al.  Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice. , 1994, Transplantation proceedings.

[4]  G. Gollin,et al.  Prolongation of allograft survival in rat heterotopic heart transplantation by TLCK, a serine protease inhibitor. , 1994, Transplantation.

[5]  F. Seiler,et al.  Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative. , 1993, Transplantation proceedings.

[6]  J. Jeekel,et al.  Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and nonimmunosuppressed rats , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  D. Kahn,et al.  Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate. Enhancement by combined immunosuppressant treatment of the recipient. , 1991, Transplantation.

[8]  K. H. Langer,et al.  Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. , 1991, Transplantation proceedings.

[9]  T. Rommel,et al.  The influence of MHC class II antigen blockade by perfusion with a monoclonal antibody on rat renal graft survival , 1991, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  S. Thiru,et al.  Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content. , 1990, Transplantation proceedings.

[11]  J. V. van Dongen,et al.  Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. , 1990, The American journal of pathology.

[12]  M. Stegall,et al.  Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Evidence of differential immunogenicity between vascularized cardiac allografts and islets. , 1990, Transplantation.

[13]  B. De,et al.  Persistence of dendritic cells and allograft antigenicity despite prolonged interim hosting of cardiac allografts in rats. , 1989 .

[14]  T. Masuko,et al.  Characterization of a CD3-like rat T cell surface antigen recognized by a monoclonal antibody. , 1989, Journal of immunology.

[15]  K. Isono,et al.  STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG‐TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATS , 1987, Transplantation.

[16]  R. Pollak,et al.  Strategies used to alter the immunogenicity of vascularized organ allografts. , 1987, Transplantation proceedings.

[17]  R. Beelen.  Monoclonal antibodies ED1, ED2, and ED3 against rat macrophages : expression of recognized antigens in different stages of differentiation , 1987 .

[18]  J. Fabre,et al.  Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat , 1985, The Journal of experimental medicine.

[19]  E. Döpp,et al.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.

[20]  J. McKenzie,et al.  THE EFFECT OF DONOR PRETREATMENT ON INTERSTITIAL DENDRITIC CELL CONTENT AND RAT CARDIAC ALLOGRAFT SURVIVAL , 1984, Transplantation.

[21]  A. Barclay.  The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. , 1981, Immunology.

[22]  W. L. Ford,et al.  Migration of lymphoblasts in the rat. Preferential localization of DNA-synthesizing lymphocytes in particular lymph nodes and other sties. , 1980, Monographs in allergy.

[23]  W. McMaster,et al.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen , 1979, European journal of immunology.

[24]  P. Häyry,et al.  PROLONGATION OF RAT CARDIAC ALLOGRAFT SURVIVAL BY DONOR PRETREATMENT: SCREENING OF ANTINEOPLASTIC DRUGS , 1978, Transplantation.

[25]  E. Friedman,et al.  PROLONGED SURVIVAL OF RABBIT SKIN AND KIDNEY ALLOGRAFTS FOLLOWING DONOR TREATMENT WITH CYTOSINE ARABINOSIDE , 1975, Transplantation.

[26]  H. Zincke,et al.  ATTEMPTED IMMUNOLOGICAL ALTERATION OF CANINE RENAL ALLOGRAFT DONORS , 1974, Transplantation.

[27]  Tilney Nl.  Patterns of lymphatic drainage in the adult laboratory rat. , 1971 .

[28]  K Ono,et al.  Improved technique of heart transplantation in rats. , 1969, The Journal of thoracic and cardiovascular surgery.

[29]  C. Carpenter,et al.  An immunosupressive site of action of heterologous antilymphocyte serum. , 1967, Lancet.